Connective Tissue Diseases  >>  prezalumab (AMG 557)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
prezalumab (AMG 557) / Amgen, AstraZeneca
NCT02391259: A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Completed
1
57
US, Europe
AMG 557, Placebo
Amgen
Systemic Lupus Erythematosus
09/11
11/11
NCT00774943: A Study of AMG 557 in Adults With Systemic Lupus Erythematosus

Completed
1
58
US, Canada
AMG 557
Amgen
Systemic Lupus Erythematosus
05/12
05/12
NCT01389895: Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus

Terminated
1
1
US, Canada, RoW
AMG 557, AMG 557 Placebo
Amgen
Cutaneous Lupus, Lupus
03/13
03/13
NCT01683695: Safety Study of AMG 557 in Subjects With Lupus Arthritis

Checkmark Top-line results in SLE and lupus related inflammatory arthritis
Mar 2018 - Mar 2018: Top-line results in SLE and lupus related inflammatory arthritis
Completed
1
20
US, Europe, RoW
AMG 557, Matching Placebo
Amgen
Lupus Arthritis, Systemic Lupus Erythematosus
03/16
03/16

Download Options